Cargando…

Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines—Heart Failure

BACKGROUND: Limited data exist to guide treatment for patients with heart failure with preserved ejection fraction and atrial fibrillation, including the important decision regarding rate versus rhythm control. METHODS AND RESULTS: We analyzed the Get With The Guidelines—Heart Failure (GWTG‐HF) regi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kelly, Jacob P., DeVore, Adam D., Wu, JingJing, Hammill, Bradley G., Sharma, Abhinav, Cooper, Lauren B., Felker, G. Michael, Piccini, Jonathan P., Allen, Larry A., Heidenreich, Paul A., Peterson, Eric D., Yancy, Clyde W., Fonarow, Gregg C., Hernandez, Adrian F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951063/ https://www.ncbi.nlm.nih.gov/pubmed/31818219 http://dx.doi.org/10.1161/JAHA.118.011560

Ejemplares similares

Regional Variations in Heart Failure Quality and Outcomes: Get With The Guidelines–Heart Failure Registry
por: Cunningham, Luke C., et al.
Publicado: (2021)

Association of Electronic Health Record Use With Quality of Care and Outcomes in Heart Failure: An Analysis of Get With The Guidelines—Heart Failure
por: Selvaraj, Senthil, et al.
Publicado: (2018)

Clinical Profile, Health Care Costs, and Outcomes of Patients Hospitalized for Heart Failure With Severely Reduced Ejection Fraction
por: Harrington, Josephine, et al.
Publicado: (2023)

Initiation, Continuation, or Withdrawal of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction
por: Gilstrap, Lauren G., et al.
Publicado: (2017)

Timing of Postdischarge Follow‐Up and Medication Adherence Among Patients With Heart Failure
por: Chang, Leslie L., et al.
Publicado: (2018)

Eligibility of sodium–glucose co‐transporter‐2 inhibitors among patients with diabetes mellitus admitted for heart failure
por: Sharma, Abhinav, et al.
Publicado: (2019)

Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction After a Recent Worsening Heart Failure Event
por: Carnicelli, Anthony P., et al.
Publicado: (2021)

Comparative Effectiveness of Primary Prevention Implantable Cardioverter‐Defibrillators in Older Heart Failure Patients With Diabetes Mellitus
por: Sharma, Abhinav, et al.
Publicado: (2020)

Impact of an Expanded Hospital Recognition Program for Heart Failure Quality of Care
por: Heidenreich, Paul A., et al.
Publicado: (2014)

Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction
por: Greene, Stephen J., et al.
Publicado: (2021)

Racial Differences in the Prevalence and Outcomes of Atrial Fibrillation Among Patients Hospitalized With Heart Failure
por: Thomas, Kevin L., et al.
Publicado: (2013)

In‐Hospital Worsening Heart Failure and Associations With Mortality, Readmission, and Healthcare Utilization
por: DeVore, Adam D., et al.
Publicado: (2014)

Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease
por: Cooper, Lauren B., et al.
Publicado: (2017)

Heart Rate at Hospital Discharge in Patients With Heart Failure Is Associated With Mortality and Rehospitalization
por: Laskey, Warren K., et al.
Publicado: (2015)

Identifying patients at increased risk for poor outcomes from heart failure with reduced ejection fraction: the PROMPT‐HF risk model
por: DeVore, Adam D., et al.
Publicado: (2021)

Rhythm versus rate control for atrial fibrillation in heart failure with preserved ejection fraction
por: Al-Sadawi, Mohammed, et al.
Publicado: (2022)

Use of Hydralazine‐Isosorbide Dinitrate Combination in African American and Other Race/Ethnic Group Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction
por: Golwala, Harsh B., et al.
Publicado: (2013)

Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection Fraction
por: Brownell, Nicholas K., et al.
Publicado: (2022)

New Strategies to Prevent Rehospitalizations for Heart Failure
por: Diamond, Jamie, et al.
Publicado: (2022)

Left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: outcomes following an acute heart failure hospitalization
por: Buggey, Jonathan, et al.
Publicado: (2017)

Short‐ and Long‐term Rehospitalization and Mortality for Heart Failure in 4 Racial/Ethnic Populations
por: Vivo, Rey P., et al.
Publicado: (2014)

Association between sacubitril/valsartan initiation and real‐world health status trajectories over 18 months in heart failure with reduced ejection fraction
por: Thomas, Merrill, et al.
Publicado: (2021)

Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP‐HF
por: Chapman, Brittany, et al.
Publicado: (2022)

Rhythm Control in Patients with Heart Failure with Preserved Ejection Fraction: A Meta-Analysis
por: Prasitlumkum, Narut, et al.
Publicado: (2021)

Heart Failure With Preserved Ejection Fraction and Obesity: Syndrome of cGMP-PKG Deficiency in Post-Menopausal Women
por: Sinha, Arjun, et al.
Publicado: (2020)

Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial
por: Sharma, Abhinav, et al.
Publicado: (2018)

Implications of peripheral oedema in heart failure with preserved ejection fraction: a heart failure network analysis
por: Fudim, Marat, et al.
Publicado: (2020)

Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes
por: Goldstein, Sarah A., et al.
Publicado: (2018)

Comparison of Machine Learning Algorithms for Predicting Hospital Readmissions and Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction: Modeling Study
por: Ru, Boshu, et al.
Publicado: (2023)

The Critical Need for Process Improvement in Heart Failure
por: Yancy, Clyde W., et al.
Publicado: (2020)

Improving implementation of evidence‐based therapies for heart failure
por: DeVore, Adam D., et al.
Publicado: (2022)

Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention
por: Khazanie, Prateeti, et al.
Publicado: (2015)

Clinical Effectiveness of Cardiac Resynchronization Therapy Versus Medical Therapy Alone Among Patients With Heart Failure: Analysis of the ICD Registry and ADHERE
por: Khazanie, Prateeti, et al.
Publicado: (2014)

Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure
por: Echols, Melvin R, et al.
Publicado: (2006)

Incremental Reduction in Risk of Death Associated With Use of Guideline-Recommended Therapies in Patients With Heart Failure: A Nested Case-Control Analysis of IMPROVE HF
por: Fonarow, Gregg C., et al.
Publicado: (2012)

Rhythm Control in Heart Failure Patients with Atrial Fibrillation
por: Eysenck, William, et al.
Publicado: (2020)

The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction
por: Brownell, Nicholas K, et al.
Publicado: (2021)

Effects of rhythm control on left atrial structure remodeling in atrial fibrillation and heart failure with preserved ejection fraction
por: Bai, Lin, et al.
Publicado: (2023)

Renin–angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta‐analysis
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2017)

Clinical profiles in acute heart failure: an urgent need for a new approach
por: Chapman, Brittany, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ek7m0hufc04f2sgttog3uj9ro7